Disease-A-Month
Volume 54, Issue 12 , Pages 751-755 , December 2008

MRSA: An Evolving Pathogen

References 

  1. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin resistant Staphylococcus aureus infections in the United States. J Am Med Assoc. 2007;298:1763–1771
  2. Flynn N, Cohen SH. The continuing saga of MRSA. J Infect Dis. 2008;197:1217–1219
  3. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococci: position statement from the joint SHEA and APIC Task Force. Inf Control Hosp Epidemiol. 2007;28:249–260
  4. Diekema DJ, Climo M. Preventing MRSA infections. J Am Med Assoc. 2008;299:1190–1192
  5. Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001;7:178–182
  6. Stewart GT, Holt RJ. Evolution of natural resistance to the new penicillins. Br Med J. 1963;1(5326):308–311
  7. Benner EJ, Kayser FH. Growing clinical significance of methicillin resistant Staphylococcus aureus.. Lancet. 1968;2:741
  8. Saravolatx LD, Markowitz N, Arking L, et al. Methicillin-resistant Staphylococcus aureus: epidemiologic observations during a community acquired outbreak. Ann Intern Med. 1982;96(1):11–16
  9. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus.. N Engl J Med. 1989;320:1188–1196
  10. Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520–532
  11. Herold BC, Immergluck LC, Maranan MC, et al. Community acquired methicillin resistant Staphylococcus aureus in children with no identified predisposing risk. J Am Med Assoc. 1998;279:593–598
  12. Centers for Disease Control. Four pediatric deaths from community acquired methicillin resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. J Am Med Assoc. 1999;282:1122–1125
  13. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin resistant Staphylococcal aureus (MRSA). Proc Natl Acad Sci U S A. 2002;99:7687
  14. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674
  15. Noskin GA, Krishnadasan A, Gorwitz RJ, et al. The burden of Staphylococcus aureus infections on hospitals in the United States. Arch Intern Med. 2005;16:1756–1761
  16. Rubin RJ, Harrington CA, Poon A, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis. 1999;5:9–17
  17. Engeman JJ, Carmilli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–599
  18. Pfaller MA, Jones RN, Doern GV, et al. Survey of blood stream infections attributable to gram positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program (SENTRY Participants Group). Diagn Microbiol Infect Dis. 1999;33:283–297
  19. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis. 2005;52:113–122
  20. Cosgrove SE, Sakoulus G, Parencevich EN, et al. Comparison of mortality associated with methicillin resistant and methicillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36:53–59

 Disclaimer: The opinions and assertions contained herein are those of the authors and are not to be construed as official or as reflecting the views of the Department of Defense, the Department of the Navy, or the naval services at large.

PII: S0011-5029(08)00121-1

doi: 10.1016/j.disamonth.2008.09.007

Disease-A-Month
Volume 54, Issue 12 , Pages 751-755 , December 2008

Article Tools